These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 30897855)

  • 21. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study.
    Smith NL; Savage PJ; Heckbert SR; Barzilay JI; Bittner VA; Kuller LH; Psaty BM
    J Am Geriatr Soc; 2002 Mar; 50(3):416-23. PubMed ID: 11943034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks and Benefits of Intermittent Fasting for the Aging Cardiovascular System.
    Ozcan M; Abdellatif M; Javaheri A; Sedej S
    Can J Cardiol; 2024 Feb; ():. PubMed ID: 38354947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-Term Effects of Healthy Eating Pattern Cycling on Cardiovascular Disease Risk Factors: Pooled Results from Two Randomized Controlled Trials.
    O'Connor LE; Li J; Sayer RD; Hennessy JE; Campbell WW
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30423846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent fasting and cardiovascular disease: A scoping review of the evidence.
    Sebastian SA; Shah Y; Arsene C
    Dis Mon; 2024 Jun; ():101778. PubMed ID: 38910053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects.
    Tay J; Brinkworth GD; Noakes M; Keogh J; Clifton PM
    J Am Coll Cardiol; 2008 Jan; 51(1):59-67. PubMed ID: 18174038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intermittent fasting on body composition and clinical health markers in humans.
    Tinsley GM; La Bounty PM
    Nutr Rev; 2015 Oct; 73(10):661-74. PubMed ID: 26374764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems.
    Mattson MP; Wan R
    J Nutr Biochem; 2005 Mar; 16(3):129-37. PubMed ID: 15741046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus.
    Huang ES; Meigs JB; Singer DE
    Am J Med; 2001 Dec; 111(8):633-42. PubMed ID: 11755507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of a successful lifestyle intervention programme for New Zealand Maori to reduce the risk of type 2 diabetes and cardiovascular disease.
    McAuley KA; Murphy E; McLay RT; Chisholm A; Story G; Mann JI; Thomson R; Bell D; Williams SM; Goulding A; Wilson N
    Asia Pac J Clin Nutr; 2003; 12(4):423-6. PubMed ID: 14672866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trials of cardiovascular risk factor management in type 2 diabetes.
    Patel A; Joshi R; de Galan B
    Curr Opin Cardiol; 2009 Jul; 24(4):288-94. PubMed ID: 19322080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intermittent fasting on metabolism in men.
    Azevedo FR; Ikeoka D; Caramelli B
    Rev Assoc Med Bras (1992); 2013; 59(2):167-73. PubMed ID: 23582559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.
    Lu J; Borthwick F; Hassanali Z; Wang Y; Mangat R; Ruth M; Shi D; Jaeschke A; Russell JC; Field CJ; Proctor SD; Vine DF
    Br J Nutr; 2011 Jun; 105(11):1572-82. PubMed ID: 21276281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity, weight loss and conditional cardiovascular risk factors.
    Tzotzas T; Evangelou P; Kiortsis DN
    Obes Rev; 2011 May; 12(5):e282-9. PubMed ID: 21054756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial.
    Sundfør TM; Svendsen M; Tonstad S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):698-706. PubMed ID: 29778565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
    Langsted A; Nordestgaard BG
    Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the effects of a diet supplemented with active components on lipid and glycemic profiles.
    Langella C; Naviglio D; Marino M; Gallo M
    Nutrition; 2015 Jan; 31(1):180-6. PubMed ID: 25466664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent fasting modulation of the diabetic syndrome in sand rats. II. In vivo investigations.
    Belkacemi L; Selselet-Attou G; Louchami K; Sener A; Malaisse WJ
    Int J Mol Med; 2010 Nov; 26(5):759-65. PubMed ID: 20878099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.